BNP Paribas Financial Markets
TNYA icon

BNP Paribas Financial Markets’s Tenaya Therapeutics TNYA Stock Holding History

BNP Paribas Financial Markets’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.15K Buy
8,327
+3,337
+67% +$2.53K ﹤0.01% 5435
2026
Q1 		$3.46K Sell
4,990
-7,354
-60% -$5.43K ﹤0.01% 5364
2025
Q4 		$8.78K Buy
12,344
+11,504
+1,370% +$15.6K ﹤0.01% 5182
2025
Q3 		$1.36K Sell
840
-2,055
-71% -$2.07K ﹤0.01% 5205
2025
Q2 		$1.77K Sell
2,895
-810
-22% -$412 ﹤0.01% 5074
2025
Q1 		$2.11K Sell
3,705
-3,144
-46% -$3.1K ﹤0.01% 4979
2024
Q4 		$9.79K Buy
+6,849
New +$15.4K ﹤0.01% 4845
2022
Q4 		– Sell
-14,857
Closed -$43.1K – 4600
2022
Q3 		$43.1K Buy
+14,857
New +$69.3K ﹤0.01% 4010

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BNP Paribas Financial Markets's TNYA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Tenaya Therapeutics (TNYA) stake by 67% in Q2 2026, buying an estimated $2.53K and bringing the position to 8,327 shares worth $6.15K. The position accounts for ﹤0.01% of the portfolio, ranked #5435.

BNP Paribas Financial Markets first reported a position in TNYA in Q3 2022 and has held it in 8 quarters since. The position peaked at $43.1K in Q3 2022. 98 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • BNP Paribas Financial Markets held 8,327 shares of Tenaya Therapeutics worth $6.15K as of Q2 2026.
  • BNP Paribas Financial Markets bought 3,337 Tenaya Therapeutics shares in Q2 2026, an estimated $2.53K.
  • Tenaya Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5435 holding.
  • BNP Paribas Financial Markets first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Tenaya Therapeutics position peaked at $43.1K in Q3 2022.
  • 98 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.